Acquired Immunodeficiency Syndrome
📧 Sign up to get email alerts when something new happens for Acquired Immunodeficiency Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection [Phase 2]
Phase 2 trial evaluating erythropoietin for anemia due to zidovudine in HIV infection has completed.
-
CLINICAL_TRIALS research · 2021-10-22Clinical Trial Update: Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea [Phase 4]
Phase 4 trial assessing the effects of crofelemer on the gut microbiome in healthy volunteers and HIV patients with non-infectious diarrhea.
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children [Phase 2, Phase 3]
Clinical trial update reporting pharmacokinetics, safety, and antiviral activity of the elvitegravir/cobicistat/emtricitabine/tenofovir alaf…
-
FDA approval · 2021-03-19FDA Approved: FOSAMPRENAVIR CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for fosamprenavir calcium from Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients [Phase 3]
Phase 3 trial update on Gardasil®9 in immunocompromised patients assessing safety, tolerability, and immunogenicity.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression [Phase 4]
Phase 4 trial evaluating a single-tablet regimen (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) as first-line therapy in trea…
-
CLINICAL_TRIALS research · 2020-08-06Clinical Trial Update: Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection [Phase 1, Phase 2]
A dual anti-HIV gene transfer construct was studied in Phase 1/2 safety trials for HIV-1 infection; the study is completed with results post…
-
FDA approval · 2020-06-18FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for RETROVIR (Zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2020-06-11FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine (AZT) by Aurobindo Pharma Limited. This approval supports a generic Zidovudine produc…
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: HIV, Buprenorphine, and the Criminal Justice System [NA]
A completed clinical trial update examining HIV, buprenorphine, and involvement with the criminal justice system; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Phase 3]
Phase 3 trial update evaluating a tablet combining two FDA-approved antiretroviral drugs for ART-experienced HIV-1 infected subjects.
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence [Phase 4]
A Phase 4 pilot study evaluated the DOT Diary App to optimize measurement of PrEP adherence and posted results in 2020.
-
FDA approval · 2020-02-10FDA Approved: ZIDOVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Zidovudine from Camber Pharmaceuticals, Inc., updating/expanding its approved use or labelin…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)
A completed regulatory post-marketing commitment study evaluating safety and efficacy of maraviroc in CCR5-tropic HIV-1 infection with resul…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Living Well Project for Persons With AIDS [NA]
Clinical trial update for the Living Well Project in persons with AIDS completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Study to Evaluate a HIV Drug for the Treatment of HIV Infection [Phase 2]
Phase 2 trial update evaluating an HIV drug for the treatment of HIV infection has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2019-09-12Clinical Trial Update: Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285 [Phase 3]
A Phase 3 trial evaluating vicriviroc added to optimized antiretroviral therapy for HIV/ AIDS was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Atazanavir/r + Lamivudine Dual Therapy [Phase 4]
Phase 4 clinical trial update of Atazanavir/ritonavir plus Lamivudine as dual therapy for HIV has completed.
-
FDA approval · 2019-07-01FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for Emtricitabine and Tenofovir Disoproxil Fumarate.
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin [Phase 4]
Phase 4 pharmacokinetic study of super-boosted lopinavir/ritonavir with rifampin was terminated.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) [Phase 3]
A Phase 3 trial comparing dolutegravir plus lamivudine versus dolutegravir plus tenofovir/emtricitabine in treatment-naïve HIV patients has …
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy
The completed trial evaluated an opt-out HIV testing strategy in pregnant women to determine if it increases testing uptake compared with st…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Behavioral Economics Field Experiment in HIV Testing [NA]
A completed field experiment at Johns Hopkins University examined behavioral economics approaches to HIV testing.
-
FDA approval · 2018-11-15FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA issued a supplemental approval for Kaletra (lopinavir/ritonavir) submitted by AbbVie.
-
FDA approval · 2018-11-15FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie. The approval updates the product under the NDA, potentia…